Literature DB >> 27919903

High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties.

Nguyen Tien Huy1,2,3, Pham Lan Chi2,4, Jun Nagai2,5, Tran Ngoc Dang6,7, Evaristus Chibunna Mbanefo2,3,4, Ali Mahmoud Ahmed8, Nguyen Phuoc Long3,6, Le Thi Bich Thoa3,6, Le Phi Hung3,6, Afaf Titouna2,4, Kaeko Kamei9, Hiroshi Ueda2,5, Kenji Hirayama10,4.   

Abstract

It is essential to continue the search for novel antimalarial drugs due to the current spread of resistance against artemisinin by Plasmodium falciparum parasites. In this study, we developed in silico models to predict hemozoin inhibitors as a potential first-step screening for novel antimalarials. An in vitro colorimetric high-throughput screening assay of hemozoin formation was used to identify hemozoin inhibitors from 9,600 structurally diverse compounds. The physicochemical properties of positive hits and randomly selected compounds were extracted from the ChemSpider database; they were used for developing prediction models to predict hemozoin inhibitors using two different approaches, i.e., traditional multivariate logistic regression and Bayesian model averaging. Our results showed that a total of 224 positive-hit compounds exhibited the ability to inhibit hemozoin formation, with 50% inhibitory concentrations (IC50s) ranging from 3.1 μM to 199.5 μM. The best model according to traditional multivariate logistic regression included the three variables octanol-water partition coefficient, number of hydrogen bond donors, and number of atoms of hydrogen, while the best model according to Bayesian model averaging included the three variables octanol-water partition coefficient, number of hydrogen bond donors, and index of refraction. Both models had a good discriminatory power, with area under the curve values of 0.736 and 0.781 for the traditional multivariate model and Bayesian model averaging, respectively. In conclusion, the prediction models can be a new, useful, and cost-effective approach for the first screen of hemozoin inhibition-based antimalarial drug discovery.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  HTS; antimalarial; compounds; hematin; heme; hemozoin; in silico model; physical properties; screening

Mesh:

Substances:

Year:  2017        PMID: 27919903      PMCID: PMC5278743          DOI: 10.1128/AAC.01607-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  43 in total

1.  Prediction of n-octanol/water partition coefficients from PHYSPROP database using artificial neural networks and E-state indices.

Authors:  I V Tetko; V Y Tanchuk; A E Villa
Journal:  J Chem Inf Comput Sci       Date:  2001 Sep-Oct

2.  Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.

Authors:  Rebecca D Sandlin; Melissa D Carter; Patricia J Lee; Jennifer M Auschwitz; Susan E Leed; Jacob D Johnson; David W Wright
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

3.  Neutralization of toxic heme by Plasmodium falciparum histidine-rich protein 2.

Authors:  Nguyen Tien Huy; Satoshi Serada; Dai Thi Xuan Trang; Ryo Takano; Yoshiro Kondo; Kenji Kanaori; Kunihiko Tajima; Saburo Hara; Kaeko Kamei
Journal:  J Biochem       Date:  2003-05       Impact factor: 3.387

4.  The iron environment in heme and heme-antimalarial complexes of pharmacological interest.

Authors:  P A Adams; P A Berman; T J Egan; P J Marsh; J Silver
Journal:  J Inorg Biochem       Date:  1996-07       Impact factor: 4.155

5.  Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression.

Authors:  Duolao Wang; Wenyang Zhang; Ameet Bakhai
Journal:  Stat Med       Date:  2004-11-30       Impact factor: 2.373

6.  Artemisinin resistance is a clear and present danger.

Authors:  Arjen M Dondorp; Pascal Ringwald
Journal:  Trends Parasitol       Date:  2013-06-12

7.  Screening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formation.

Authors:  S Vargas; K Ndjoko Ioset; A-E Hay; J-R Ioset; S Wittlin; K Hostettmann
Journal:  J Pharm Biomed Anal       Date:  2011-07-05       Impact factor: 3.935

8.  The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs.

Authors:  J Zhang; M Krugliak; H Ginsburg
Journal:  Mol Biochem Parasitol       Date:  1999-03-15       Impact factor: 1.759

9.  In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.

Authors:  A K Tripathi; A Gupta; S K Garg; B L Tekwani
Journal:  Life Sci       Date:  2001-10-26       Impact factor: 5.037

10.  A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; José Francisco Fernandes; Béatrice Peggy Abossolo; Barbara Gaelle Nfono Ondo Methogo; Anita Lumeka Kabwende; Ayola Akim Adegnika; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Sonia Machevo; Sozinho Acacio; Helder Bulo; Betuel Sigauque; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Rose Minja; Maxmillian Mpina; Saumu Ahmed; Ali Mohammed Ali; Ali Takadir Mtoro; Ali Said Hamad; Paul Mutani; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Biébo Bihoun; Issa Guiraud; Berenger Kaboré; Olivier Sombié; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Martina Oneko; Chris Odero; Kephas Otieno; Norbert Awino; Meredith McMorrow; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Nekoye Otsyula; Stacey Gondi; Allan Otieno; Victorine Owira; Esther Oguk; George Odongo; Jon Ben Woods; Bernhards Ogutu; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Charity Maingi; Trudie Lang; Ally Olotu; Philip Bejon; Kevin Marsh; Gabriel Mwambingu; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; David Dosoo; Isaac Asante; George Adjei; Evans Kwara; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Coline Mahende; Edwin Liheluka; Lincoln Malle; Martha Lemnge; Thor G Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Anima Sarfo; Alex Agyekum; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Rutendo Nkomo; Tapiwa Tembo; Gerald Tegha; Mercy Tsidya; Jane Kilembe; Chimwemwe Chawinga; W Ripley Ballou; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Aurélie Olivier; Johan Vekemans; Terrell Carter; David Kaslow; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2012-11-09       Impact factor: 91.245

View more
  3 in total

1.  Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties.

Authors:  Farhana Mosaddeque; Shusaku Mizukami; Mohamed Gomaa Kamel; Awet Alem Teklemichael; Truong Van Dat; Satoshi Mizuta; Dinh Van Toan; Ali Mahmoud Ahmed; Nguyen Lam Vuong; Mohamed Tamer Elhady; Hoang Thi Nam Giang; Tran Ngoc Dang; Michiko Fukuda; Lam K Huynh; Yoshimasa Tanaka; Timothy J Egan; Osamu Kaneko; Nguyen Tien Huy; Kenji Hirayama
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

2.  Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.

Authors:  Ana Carolina C de Sousa; Keletso Maepa; Jill M Combrinck; Timothy J Egan
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

3.  Antimalarial Quinoline Drugs Inhibit β-Hematin and Increase Free Hemin Catalyzing Peroxidative Reactions and Inhibition of Cysteine Proteases.

Authors:  Tomás Herraiz; Hugo Guillén; Diana González-Peña; Vicente J Arán
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.